Title:
POLYMORPHS OF CRYSTALLINE FORMS OF 3, 10-DIMETHOXY-5, 8, 13, 13A-TETRAHYDRO-6H-ISOQUINOLINO [3, 2-A] ISOQUINOLIN-9-YL 3-FLUOROBENZENESULFONATE AND SALTS THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/048620
Kind Code:
A1
Abstract:
Crystalline salts of compounds, methods of making the same, and methods of treatment of dyslipidemia including administration of the crystalline salts, are provided.
More Like This:
JPH03161440 | ANTIBACTERIAL AGENT |
WO/1998/013368 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS |
JP2011046716 | METHOD FOR TREATING CANCER AND METHOD RELATED TO THE SAME |
Inventors:
SHI SHENYI (CN)
WANG FENG (CN)
LIU JINGWEN (KY)
YANG JIAN (CN)
WANG FENG (CN)
LIU JINGWEN (KY)
YANG JIAN (CN)
Application Number:
PCT/CN2021/116364
Publication Date:
March 10, 2022
Filing Date:
September 03, 2021
Export Citation:
Assignee:
CVI PHARMACEUTICALS LTD (GB)
SHI SHENYI (CN)
SHI SHENYI (CN)
International Classes:
C07D471/04; A61K31/4375; A61P3/10
Domestic Patent References:
WO2010075469A1 | 2010-07-01 |
Foreign References:
US8710071B2 | 2014-04-29 |
Other References:
HILFIKER R (EDITOR) ED - HILFIKER R: "Polymorphism in the Pharmaceutical Industry", 1 January 2006, 20060101, PAGE(S) 1 - 19, ISBN: 978-3-527-31146-0, XP002528052
Attorney, Agent or Firm:
BEIJING PAT SF INTELLECTUAL PROPERTY AGENCY CO. LTD (CN)
Download PDF: